Compare Prologis Inc (PLD) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Prologis Inc vs Smith & Nephew plc — how do they compare? Prologis Inc trades at $144.35 (market cap $139.79B), while Smith & Nephew plc trades at $29.95 (market cap $12.71B). The key difference: Prologis Inc is far larger — about 11× Smith & Nephew plc's market cap, and Prologis Inc pays the higher dividend (2.85%). Which is the better fit depends on your goals.
| PLD | SNN | |
|---|---|---|
Market Cap | $139.79B | $12.71B |
Sector | Real Estate | Health |
52-Week High | $149.96 | $38.70 |
52-Week Low | $104.08 | $28.73 |
Enterprise Value | $174.47B | $15.48B |
Dividend Yield | 2.85% | 2.59% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Prologis Inc
Prologis was formed by the June 2011 merger of AMB Property and Prologis Trust. The company develops, acquires, and operates around 1 billion square feet of high-quality industrial and logistics facilities across the globe. The company also has a strategic capital business segment that has around $70 billion of third-party AUM. The company is organized into four global divisions (Americas, Europe, Asia, and other Americas) and operates as a real estate investment trust.
Read more on PLD →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
